TUBERSOL®, a product of Sanofi Pasteur Limited, is in shortage nationwide until further notice.
TUBERSOL® is one of two purified-protein derivative (PPD) tuberculin products that are licensed by the United States Food and Drug Administration (FDA). The manufacturer notified CDC that 50-dose vials of TUBERSOL® are unavailable and that the supplies of 10-dose vials are limited.
For this reason, Wassaja Memorial Health Center is unable to provide PPD placement (TB screening) on patients for screening purposes until the shortage has resolved.
If you are in need of TB screening, please make an appointment with your doctor to see what options are available to you.
